|Articles|December 1, 2015

Spectroscopy

  • Spectroscopy-12-01-2015
  • Volume 30
  • Issue 12

Specac Inc

Company Description

Specac is a leading manufacturer of high quality FT-IR accessories and sample preparation products. They regularly bring new and innovative solutions to the market.

Nobody makes more user-friendly or accurate products. ATR, diffuse reflectance, specular reflectance, and transmission are among the techniques served.

Pellets, discs, or films are covered by Specac's Atlas range of pressing solutions. From small low tonnage manual hydraulic presses to 40 ton fully programmable automatic presses, the Atlas range covers most areas. Specac products serve universities, research and development, forensics, pharmaceutical and oil industries and more.

Chief Spectroscopic Techniques Supported

  • Infrared transmission

  • Infrared reflectance

  • Polarizers

  • Process cells and XRF/XRD

Major Products/Services

Specac's range (fit most spectrometers) includes:

  • The Pearl liquid transmission accessory

  • Golden Gate ATR

  • Quest ATR

  • Omni-Cell

  • Gas Cells

  • Atlas Manual, Power and Automatic Presses (2–40 maximum load)

  • Polarizers

Facility

Specac has offices in the USA and UK and has a global network of dealers and distributors.

Specac Inc.
414 Commerce Dr. #175, Fort Washington, PA 19034

TELEPHONE
(215) 793-40448

FAX
(215) 793-4011

E-MAILsales@specac.com

WEB SITEwww.specac.com

YEAR FOUNDED
1971

Articles in this issue

Related to this article

Richard Crocombe
The New York / New Jersey Section of the Society for Applied Spectroscopy will present its 2026 Gold Medal Award to Richard Crocombe at the Eastern Analytical Symposium on November 17, recognizing two decades of work that helped carry spectroscopy out of the laboratory and into the field.
Highlights from What’s Nu October 2026
In this Q&A, we recap the October edition of “What’s Nu,” which covered topics such as how novel spectroscopic and analytical methods are transforming environmental monitoring, medical treatment, and accessibility in scientific research.